China’s investigations into Taiwanese supplier Foxconn come as its billionaire founder pursues a bid for the Taiwanese presidency.

The automaker is abandoning a self-imposed target for the number of electric vehicles it aims to produce through the middle of next year.

The conglomerate said efforts to improve performance and control costs are bearing fruit.

The deal is the latest example of a big pharma company turning to the deal table to bolster its pipeline of autoimmune drugs.

Apple is increasingly reliant on China-based Luxshare for manufacturing amid U.S. tensions with Beijing.

The all-stock deal is the latest sign of consolidation in an oil-and-gas industry flush with cash.